Corcept Therapeutics Incorporated
Large Cap · Healthcare · Biotechnology
$114.53+$4.02 (+3.64%)
Corcept Therapeutics Incorporated
Large Cap · Healthcare · Biotechnology
$114.53+$4.02 (+3.64%)
Stock analysis
Get the AI take on CORT
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$28.66
High$95.79
Today $114.53
RSI (14)
64.8Neutral
03070100
Overall score
52/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$50
Current price
$114.53
Median target
$163
Highest
$165
LowHigh
Operating Record
Revenue
What's working
- Cash exceeds debt by $535.2M, leaving a net cash buffer, a good sign.
- Debt / equity: Light borrowing means a rough patch wouldn't threaten the balance sheet.
What to watch
- Forward P/E: The price already assumes strong earnings growth that still has to show up.
- Price / sales: Revenue alone can't justify this price; profits need to catch up fast.
What the market charges
Forward P/E
Needs attention · 87% above avg
28.96x
Price / sales
Rich · Priced well above what its revenue alone supports
14.89x
Price / FCF
Rich · Priced far above what its cash flow currently supports
115.73x
EV / EBITDA
Rich · Operating earnings don't yet support this price
1464.47x
How efficiently it compounds
ROIC
Weak · Struggling to earn much on the capital it uses
1.8%
ROE
Needs attention · Unfavorable
8.2%
Debt / equity
Favorable · 0.02 - strong leverage
0.01x
Current ratio
Strong · Comfortable room to cover bills due within a year
2.86x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $12.37B | 273.4 | +16.0% | 52 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |